{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0008315,73,MONDO:0008315,32,1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0008315","source":"MONDO:0008315|prostate cancer","targets":["NCT00029224|Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions|COMPLETED|PHASE4|INTERVENTIONAL","NCT00035997|Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00063609|The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00103623|The Plenaxis® Experience Study|SUSPENDED|PHASE4|INTERVENTIONAL","NCT00106392|A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00185029|MR-Lymphography and Lymph Node Staging in Prostate Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00199485|Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00219219|Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases|COMPLETED|PHASE4|INTERVENTIONAL","NCT00219271|Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00237146|Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00242554|Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases|COMPLETED|PHASE4|INTERVENTIONAL","NCT00280098|Docetaxel in the Treatment of Hormone Refractory Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00293696|Casodex/Zoladex Biomarkers in Localised Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00334139|Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00375765|Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00391690|Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00422708|Local Anesthesia for Prostate Biopsy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00526331|Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00590213|Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX|COMPLETED|PHASE4|INTERVENTIONAL","NCT00629330|Dissemination of Prostate Cancer Screening to PCP's in African American Communities|TERMINATED|PHASE4|INTERVENTIONAL","NCT00648323|Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement|COMPLETED|PHASE4|INTERVENTIONAL","NCT00771966|Radical Prostatectomy and Perioperative Fluid Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00805701|Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation|COMPLETED|PHASE4|INTERVENTIONAL","NCT00859027|Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00906269|Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00953277|Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00982800|Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy?|COMPLETED|PHASE4|INTERVENTIONAL","NCT01083199|Global Performance Evaluation of the AMS CONTINUUM™ Device|COMPLETED|PHASE4|INTERVENTIONAL","NCT01118260|Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection|COMPLETED|PHASE4|INTERVENTIONAL","NCT01136226|Evaluate Recovery of Testosterone for Patients Using Eligard|COMPLETED|PHASE4|INTERVENTIONAL","NCT01161563|Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration|COMPLETED|PHASE4|INTERVENTIONAL","NCT01230905|Study to Monitor the Effects of Androgen Suppression Treatment on the Heart|COMPLETED|PHASE4|INTERVENTIONAL","NCT01296672|3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT01365143|Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy|TERMINATED|PHASE4|INTERVENTIONAL","NCT01379742|Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01486563|Hydroxyethyl Starch and Renal Function After Radical Prostatectomy|COMPLETED|PHASE4|INTERVENTIONAL","NCT01511874|Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT01512472|Firmagon (Degarelix) Intermittent Therapy|TERMINATED|PHASE4|INTERVENTIONAL","NCT01547416|The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function|COMPLETED|PHASE4|INTERVENTIONAL","NCT01571544|The Use of Thermal Suits as Preventing Hypothermia During Surgery|COMPLETED|PHASE4|INTERVENTIONAL","NCT01581749|Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01649635|Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT01673984|GP Extended Action Triptorelin|TERMINATED|PHASE4|INTERVENTIONAL","NCT01753297|A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.|COMPLETED|PHASE4|INTERVENTIONAL","NCT01794793|Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies|COMPLETED|PHASE4|INTERVENTIONAL","NCT01950871|Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning|TERMINATED|PHASE4|INTERVENTIONAL","NCT01995513|Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT02001857|Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.|COMPLETED|PHASE4|INTERVENTIONAL","NCT02102646|MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism|COMPLETED|PHASE4|INTERVENTIONAL","NCT02116582|A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT02149628|The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide|COMPLETED|PHASE4|INTERVENTIONAL","NCT02405858|A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT02441517|A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment|TERMINATED|PHASE4|INTERVENTIONAL","NCT02441894|Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT02469454|Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development|COMPLETED|PHASE4|INTERVENTIONAL","NCT02475057|Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists|COMPLETED|PHASE4|INTERVENTIONAL","NCT02511665|Metformin And Longevity|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02651948|Transperineal, MRI-guided, Prostate Biopsy|COMPLETED|PHASE4|INTERVENTIONAL","NCT02695784|Probiotics After Discharge|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02721433|4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases|COMPLETED|PHASE4|INTERVENTIONAL","NCT02726009|A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT02749825|Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer|TERMINATED|PHASE4|INTERVENTIONAL","NCT02757365|Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02773251|The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery|COMPLETED|PHASE4|INTERVENTIONAL","NCT02812186|Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery|COMPLETED|PHASE4|INTERVENTIONAL","NCT02818816|Preoperative Brimonidine on IOP of Patients Undergoing RALP|COMPLETED|PHASE4|INTERVENTIONAL","NCT02909049|Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy|COMPLETED|PHASE4|INTERVENTIONAL","NCT02918968|Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT03006562|PREvention of VENous ThromboEmbolism Following Radical Prostatectomy|TERMINATED|PHASE4|INTERVENTIONAL","NCT03016741|Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT03035032|A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT03202381|Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03228108|Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.|COMPLETED|PHASE4|INTERVENTIONAL","NCT03641560|A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT03693287|Personalized vs Standardized PN for Preterm Infants >1250g|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03796195|(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes|TERMINATED|PHASE4|INTERVENTIONAL","NCT03824808|Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery|TERMINATED|PHASE4|INTERVENTIONAL","NCT03971110|A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.|TERMINATED|PHASE4|INTERVENTIONAL","NCT04108208|A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT04134208|An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer|TERMINATED|PHASE4|INTERVENTIONAL","NCT04248621|Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04549207|Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT04882618|Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05068180|Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05304169|Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.|COMPLETED|PHASE4|INTERVENTIONAL","NCT05457257|Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations|COMPLETED|PHASE4|INTERVENTIONAL","NCT05568537|Prostate MRI and Pylarify PSMA PET/CT|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT05629494|Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test|RECRUITING|PHASE4|INTERVENTIONAL","NCT05631080|Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05700903|Contributions to Hypertension With Androgen Deprivation Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT05722925|Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT05753046|Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain|ENROLLING_BY_INVITATION|PHASE4|INTERVENTIONAL","NCT05803096|Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain|COMPLETED|PHASE4|INTERVENTIONAL","NCT05803941|Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer|RECRUITING|PHASE4|INTERVENTIONAL","NCT05805436|Preop Laxatives in Robotic Urologic Surgery|RECRUITING|PHASE4|INTERVENTIONAL","NCT05919329|Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy|RECRUITING|PHASE4|INTERVENTIONAL","NCT05957653|Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05957822|Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery|RECRUITING|PHASE4|INTERVENTIONAL","NCT06001619|Prostate Medication, Metabolism and Gut Microbiota|RECRUITING|PHASE4|INTERVENTIONAL","NCT06074510|PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL"]}]}